Structure Therapeutics American Stock Probability of Future Stock Price Finishing Under 52.44
| GPCR Stock | 34.01 0.60 1.80% |
Structure |
Structure Therapeutics Target Price Odds to finish below 52.44
The tendency of Structure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under 52.44 after 90 days |
| 34.01 | 90 days | 52.44 | close to 99 |
Based on a normal probability distribution, the odds of Structure Therapeutics to stay under 52.44 after 90 days from now is close to 99 (This Structure Therapeutics American probability density function shows the probability of Structure Stock to fall within a particular range of prices over 90 days) . Probability of Structure Therapeutics price to stay between its current price of 34.01 and 52.44 at the end of the 90-day period is under 95 .
Given the investment horizon of 90 days Structure Therapeutics has a beta of 0.69. This usually indicates as returns on the market go up, Structure Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Structure Therapeutics American will be expected to be much smaller as well. Additionally Structure Therapeutics American has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Structure Therapeutics Price Density |
| Price |
Predictive Modules for Structure Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Structure Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Structure Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Structure Therapeutics is not an exception. The market had few large corrections towards the Structure Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Structure Therapeutics American, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Structure Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.25 | |
β | Beta against Dow Jones | 0.69 | |
σ | Overall volatility | 2.89 | |
Ir | Information ratio | -0.07 |
Structure Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Structure Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Structure Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Structure Therapeutics generated a negative expected return over the last 90 days | |
| Structure Therapeutics has high historical volatility and very poor performance | |
| Structure Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (89.62 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Structure Therapeutics generates negative cash flow from operations | |
| Structure Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Companies Like Structure Therapeutics Are In A Position To Invest In Growth |
Structure Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Structure Stock often depends not only on the future outlook of the current and potential Structure Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Structure Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.7 M | |
| Cash And Short Term Investments | 467.3 M |
Structure Therapeutics Technical Analysis
Structure Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Structure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Structure Therapeutics American. In general, you should focus on analyzing Structure Stock price patterns and their correlations with different microeconomic environments and drivers.
Structure Therapeutics Predictive Forecast Models
Structure Therapeutics' time-series forecasting models is one of many Structure Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Structure Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Structure Therapeutics
Checking the ongoing alerts about Structure Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Structure Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Structure Therapeutics generated a negative expected return over the last 90 days | |
| Structure Therapeutics has high historical volatility and very poor performance | |
| Structure Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (89.62 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Structure Therapeutics generates negative cash flow from operations | |
| Structure Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Companies Like Structure Therapeutics Are In A Position To Invest In Growth |
Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.